Dihydrouracil

From WikiMD's WELLNESSPEDIA

Chemical structure of Dihydrouracil

Dihydrouracil is a chemical compound that belongs to the class of pyrimidine derivatives. It is a reduced form of uracil, which is one of the four nucleobases found in RNA. Dihydrouracil is formed through the reduction of uracil by the enzyme dihydropyrimidine dehydrogenase (DPD). This enzyme plays a crucial role in the metabolism of pyrimidine nucleotides.

Structure and Properties[edit]

Dihydrouracil has a molecular formula of C4H6N2O2 and a molecular weight of 114.10 g/mol. It is a white crystalline solid that is soluble in water. The compound exists in two tautomeric forms, keto and enol, with the keto form being the more stable one.

Biological Significance[edit]

Dihydrouracil is an important intermediate in the metabolism of uracil and other pyrimidine nucleotides. It is produced as a byproduct during the degradation of thymine and uracil in the body. Dihydrouracil is further metabolized to β-alanine by the enzyme dihydropyrimidinase. β-alanine is then used in the synthesis of pantothenic acid, a component of coenzyme A.

Clinical Significance[edit]

Dihydrouracil has gained attention in the field of pharmacology due to its association with the efficacy and toxicity of certain drugs. The enzyme DPD, responsible for the conversion of uracil to dihydrouracil, is involved in the metabolism of several chemotherapeutic agents, such as 5-fluorouracil (5-FU). Variations in the DPD enzyme activity can affect the response to these drugs, leading to differences in drug efficacy and toxicity among individuals.

References[edit]


See Also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.